Valentina Robila, Ph.D. - Publications

2007 University of Virginia, Charlottesville, VA 

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Ostankovitch M, Altrich-Vanlith M, Robila V, Engelhard VH. N-glycosylation enhances presentation of a MHC class I-restricted epitope from tyrosinase. Journal of Immunology (Baltimore, Md. : 1950). 182: 4830-5. PMID 19342661 DOI: 10.4049/Jimmunol.0802902  0.561
2008 Robila V, Ostankovitch M, Altrich-Vanlith ML, Theos AC, Drover S, Marks MS, Restifo N, Engelhard VH. MHC class II presentation of gp100 epitopes in melanoma cells requires the function of conventional endosomes and is influenced by melanosomes. Journal of Immunology (Baltimore, Md. : 1950). 181: 7843-52. PMID 19017974 DOI: 10.4049/Jimmunol.181.11.7843  0.577
2005 Ostankovitch M, Robila V, Engelhard VH. Regulated folding of tyrosinase in the endoplasmic reticulum demonstrates that misfolded full-length proteins are efficient substrates for class I processing and presentation. Journal of Immunology (Baltimore, Md. : 1950). 174: 2544-51. PMID 15728460 DOI: 10.4049/Jimmunol.174.5.2544  0.539
2001 Mullins DW, Bullock TN, Colella TA, Robila VV, Engelhard VH. Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice. Journal of Immunology (Baltimore, Md. : 1950). 167: 4853-60. PMID 11673489 DOI: 10.4049/Jimmunol.167.9.4853  0.398
Show low-probability matches.